Released on = April 24, 2006, 3:19 pm

Press Release Author = CaraMedica

Industry = Pharmaceuticals

Press Release Summary = araMedica Pharmaceuticals, Inc., an emerging sales,
marketing and development company focused on the cosmetic surgery market, announced
the national launch of the BioCorneum® product line today.

Press Release Body = Research Triangle Park, North Carolina - April 24, 2006 -
CaraMedica Pharmaceuticals, Inc., an emerging sales, marketing and development
company focused on the cosmetic surgery market, announced the national launch of the
BioCorneum® product line today. BioCorneum® is a patented, topical, self-drying
silicone gel scar treatment which is only available to patients from licensed
medical professionals. A spray version of the product will be released in late
2006.

Under a distribution agreement with Seattle-based Advanced Bio-Technologies, Inc,
CaraMedica has obtained the exclusive right to market BioCorneum® to cosmetic
surgeons and dermatologists in the USA. CaraMedica's pharmaceutical sales
representatives will begin selling BioCorneum® nationwide April 23, 2006.

BioCorneum®, classified by the FDA under a 510(k) as a medical device, manages old
and new scars, and prevents the formation of keloids, hypertrophic and atrophic
scars resulting from surgery, trauma, burns and skin infections. When applied to the
affected area, it suppresses growth factors that lead to scarring, while protecting
tissue against physical, chemical and microbial invasion. BioCorneum® rapidly
self-dries, offering patients a discreet, effective and convenient way to treat
scars.

The launch of the BioCorneum product line marks a milestone for CaraMedica that
executives anticipate will bring dramatic and sustained growth for the company.
Numbers for the cosmetic surgery industry point to a booming market. According to
the American Society for Aesthetic Plastic Surgery, approximately 11.9 million
cosmetic procedures were performed in the U.S. in 2004, a 44% increase from the
previous year. "CaraMedica is well poised to capitalize on this growth with a
portfolio of patented prescription and cosmeceutical products that enable patients
to shorten recovery time, accelerate results and extend the benefits of surgery,"
commented Damon Race, CEO of CaraMedica.

# # #

About CaraMedica Pharmaceuticals Inc.
CaraMedica Pharmaceuticals is an emerging marketing, sales and development company
based in Research Triangle Park, North Carolina. CaraMedica offers cosmetic surgeons
and dermatologists an exclusive portfolio of patented and proprietary prescription
and cosmeceutical products. For more information about CaraMedica, visit
http://www.caramedica.com






Web Site = http://www.caramedica.com

Contact Details = David Chapman/919 Marketing
919-557-7890
dchapman@919marketing.com